Beijing Foyou Pharma CO.,LTD (SHA:601089)

SHA:601089 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	3,410	3,433	3,328	3,237	2,838	2,535
Other Revenue	14.25	12.36	11.97	3.15	-	-
Revenue	3,424	3,446	3,340	3,240	2,838	2,535
Revenue Growth (YoY)	1.75%	3.17%	3.07%	14.18%	11.93%	4.56%
Cost of Revenue	1,143	1,145	1,128	1,040	874.82	733.76
Gross Profit	2,281	2,301	2,212	2,200	1,963	1,802
Selling, General & Admin	1,378	1,392	1,353	1,492	1,403	1,341
Research & Development	393.66	417.37	353.33	238.4	176.87	138.16
Other Operating Expenses	37.1	21.85	26.27	34.56	30.43	23.62
Operating Expenses	1,810	1,833	1,730	1,767	1,608	1,504
Operating Income	470.62	468.41	481.62	432.97	354.75	297.35
Interest Expense	-2.44	-3.5	-5.34	-4.76	-6.51	-11.1
Interest & Investment Income	38.45	49.25	58.02	35.83	7.98	6.05
Currency Exchange Gain (Loss)	0.33	0.37	0.05	0.39	-0.06	-0.23
Other Non Operating Income (Expenses)	-0.41	-0.63	-0.68	-1.18	-2.48	-1.01
EBT Excluding Unusual Items	506.55	513.91	533.67	463.25	353.68	291.05
Gain (Loss) on Sale of Assets	-6.82	1.04	0.23	0.14	0.01	-0.65
Asset Writedown	-	-	-	-	-1.13	-10.39
Legal Settlements	-	-	-	-	-0.54	-
Other Unusual Items	22.98	25.17	15.26	22.56	13.67	19.77
Pretax Income	523.01	540.12	549.15	485.95	365.69	299.78
Income Tax Expense	54.9	48.04	56.81	46.33	49.79	35.28
Earnings From Continuing Operations	468.11	492.08	492.34	439.62	315.91	264.5
Minority Interest in Earnings	-2.19	-3.4	-3.57	-0.72	-1.44	-1.79
Net Income	465.92	488.67	488.77	438.9	314.47	262.71
Net Income to Common	465.92	488.67	488.77	438.9	314.47	262.71
Net Income Growth	-11.94%	-0.02%	11.36%	39.57%	19.70%	20.09%
Shares Outstanding (Basic)	471	470	479	422	361	360
Shares Outstanding (Diluted)	471	470	479	422	361	360
Shares Change (YoY)	-1.23%	-1.94%	13.55%	16.75%	0.44%	0.35%
EPS (Basic)	0.99	1.04	1.02	1.04	0.87	0.73
EPS (Diluted)	0.99	1.04	1.02	1.04	0.87	0.73
EPS Growth	-10.84%	1.96%	-1.92%	19.54%	19.18%	19.67%
Free Cash Flow	56.09	299.23	189.82	524.36	335.05	217.69
Free Cash Flow Per Share	0.12	0.64	0.40	1.24	0.93	0.60
Dividend Per Share	0.500	0.500	0.500	0.400	0.300	0.300
Dividend Growth	-	-	25.00%	33.33%	-	-
Gross Margin	66.61%	66.78%	66.22%	67.91%	69.17%	71.06%
Operating Margin	13.74%	13.59%	14.42%	13.36%	12.50%	11.73%
Profit Margin	13.61%	14.18%	14.64%	13.55%	11.08%	10.36%
Free Cash Flow Margin	1.64%	8.68%	5.68%	16.18%	11.81%	8.59%
EBITDA	561.86	551.98	561.39	499.93	413.17	341.56
EBITDA Margin	16.41%	16.02%	16.81%	15.43%	14.56%	13.47%
D&A For EBITDA	91.24	83.57	79.77	66.96	58.42	44.22
EBIT	470.62	468.41	481.62	432.97	354.75	297.35
EBIT Margin	13.74%	13.59%	14.42%	13.36%	12.50%	11.73%
Effective Tax Rate	10.50%	8.89%	10.35%	9.53%	13.61%	11.77%
Revenue as Reported	3,424	3,446	3,340	3,240	-	-
Advertising Expenses	-	37.65	45.32	25.17	26.19	20.97

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.